semaglutide backorder The Shortage Is Ending: What's Next For Compounded Drugs? FDA Ends Semaglutide Shortage Listing,

In its Phase 3 trial results announced in May 2026, participants on the highest dose lost around 28 to 30 percent of their body weight over roughly two years, figures that put it ahead of most other weight loss medicines studied so far

For a stretch in 2022 to 2024, semaglutide and tirzepatide were on that shortage list, which is part of why compounded versions became so widely available

The news: GLP-1 usage in the US is at a record high, according to a new Gallup poll

We love discussing proteins

But I was also incredibly cautious because I'm aware that with any medication, if it's strong enough to help, it's also strong enough to hurt